MOL ONCOL 润色咨询

Molecular Oncology

出版年份:2007 年文章数:1571 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:1.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=784c10621, cover=https://img.medsci.cn/images/journal/cover/2021/qQu_202109271316065980.jpg, fullname=Molecular Oncology, abbr=MOL ONCOL, pyear=2007, frequence=Quarterly, articleNumbers=1571, citedSelf2015=1.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.13月, reviewFee=null, pageFee=3300.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1574-7891, greenSci=https://www.greensci.net/search?kw=1574-7891, scijournal=https://www.scijournal.org/impact-factor-of-MOL-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=17.513, medsciHotlight=20.313, medsciHotlight5year=21.2091, citescore=10.0, hIndex=88, impactFactor=6.6, orgnization=John Wiley and Sons Ltd, orgnizationUrl=http://www.elsevier.com, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/, websiteHits=18779, guideForAuthor=http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/journal-menu/author-guidelines.html, guideForAuthorHits=1147, submitWebsite=https://mc.manuscriptcentral.com/molonc, submitWebsiteHits=9072, content=<p style="margin: 0px 0px 1.15385em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.5em; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"=""><i style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; user-select: text !important;"><span style="font-weight: 700; margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; user-select: text !important;">Molecular Oncology</span></i> is an Open Access international journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research.</p><p style="margin: 0px 0px 1.15385em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.5em; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients.</p><p style="margin: 0px 0px 1.15385em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.5em; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Topics include, but are not limited to:</p><ul style="margin: 0px 0px 1.15385em 1.53846em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"=""><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Biomarkers: diagnosis, prognosis, stratification and efficacy.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Cancer genetics, epigenetics, and genomic instability.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Minimal residual disease, pre-malignant lesions.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Cancer micro-environment.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Molecular pathology.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Tumour immunology.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Translational research.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Chemotherapy, radiotherapy and surgery.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Clinical pharmacology.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Clinical trials, integration of basic science into cancer clinical trials.</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Molecular epidemiology.</li></ul><h3 style="margin: 0px 0px 5px; padding: 0px; border: 0px; outline: 0px; font-size: 1.07692em; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.2em; font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Coverage</h3><p style="margin: 0px 0px 1.15385em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.5em; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"=""></p><ul style="margin: 0px 0px 1.15385em 1.53846em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"=""><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Research articles</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Reviews (these are invited only)</li><li style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; line-height: 1.5em; user-select: text !important;">Science policy articles</li></ul><h3 style="margin: 0px 0px 5px; padding: 0px; border: 0px; outline: 0px; font-size: 1.07692em; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.2em; font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Submitting Authors</h3><p style="margin: 0px 0px 1.15385em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.5em; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"=""></p><p style="margin: 0px 0px 1.15385em; padding: 0px; border: 0px; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 1.5em; color: rgb(66, 66, 66); font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">From the 1st of August 2016, manuscripts can be submitted to <i style="margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; background: 0px 0px; user-select: text !important;">Molecular Oncology </i>at: <a href="https://mc.manuscriptcentral.com/molonc" target="_blank" style="margin: 0px; padding: 0px; vertical-align: baseline; background: 0px 0px; color: rgb(64, 64, 64); font-weight: 700; text-decoration-line: none; user-select: text !important;">https://mc.manuscriptcentral.com/molonc</a></p>, totalCites=10372, brief=MOL ONCOL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的优秀级杂志, articleType=论著,综述各类型文章都接收, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=MOL ONCOL 在该细分领域可能是国际一流杂志,但是国内关注少,可能与很难投中有关吧,可以试试,但不要报过高中的期望哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=784c10621'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=22), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=18), ImpactFactorTagDto(id=11469, tagName=肿瘤标记物, createdHits=2), ImpactFactorTagDto(id=14566, tagName=分子, createdHits=1), ImpactFactorTagDto(id=4407, tagName=机制, createdHits=1), ImpactFactorTagDto(id=41103, tagName=分子生物, createdHits=1), ImpactFactorTagDto(id=66041, tagName=high throughput, createdHits=1), ImpactFactorTagDto(id=1777, tagName=肿瘤干细胞, createdHits=1), ImpactFactorTagDto(id=48535, tagName=肿瘤凋亡, createdHits=1), ImpactFactorTagDto(id=19995, tagName=信号途径, createdHits=1), ImpactFactorTagDto(id=29982, tagName=肿瘤进展, createdHits=1), ImpactFactorTagDto(id=112373, tagName=肿瘤血管发育, createdHits=1), ImpactFactorTagDto(id=57697, tagName=autophagy, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.25), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.17), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.64), GetImpactFactorCiteScoreListResponse(year=2019, citescore=9.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=10.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=29.108), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=23.35), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=21.038), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=18.852), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=17.513)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=30/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Genetics , rank=31/318), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=17/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=28/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-7891[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MOLECULAR ONCOLOGY[ta], article_number=235, article_number_cn=46, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MOL ONCOL/Molecular Oncology
ISSN
1574-7891
影响指数话题
预警等级
MedSci期刊指数
17.513 (MedSci实时期刊指数) | 21.2091 (5年期刊指数)
CiteScore值
10.0
h-index
88
h5-median
暂无数据
出版社/管理机构
杂志由 John Wiley and Sons Ltd 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Quarterly
出版年份
2007
是否OA
被收录情况
Science Citation Index Expanded|BIOSIS Previews
JCR分区
ONCOLOGY Q1
中科院分区
大类:医学 2区
小类:医学 2 区